STOCK PURCHASE AGREEMENT By and Between SMITHKLINE BEECHAM CORPORATION AND GLAXO GROUP LIMITED AND PRAECIS PHARMACEUTICALS INCORPORATED Dated as of April 7, 2006Stock Purchase Agreement • August 4th, 2006 • Praecis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of April 7, 2006, by and between SmithKline Beecham Corporation, a corporation organized under the laws of Pennsylvania, having a principal place of business at One Franklin Plaza, 200 N. 16th Street, Philadelphia, Pennsylvania 19102 (“SBC”) and Glaxo Group Limited, a company organized under the laws of England and Wales, having its registered office at Glaxo Wellcome House, Berkeley Avenue Greenford, Middlesex, UB6 ONN, United Kingdom (“GGL”, and with SBC collectively, the “Investor” and each sometimes referred to herein as an “Investor”), and PRAECIS PHARMACEUTICALS INCORPORATION (the “Company”), a corporation organized under the laws of Delaware with its principal place of business at 830 Winter Street, Waltham, Massachusetts 02451-1420.
